Abreu, Cristina

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial

Gomez-Peralta, F., Abreu, C., Fernández-Rubio, E., Cotovad, L., Pujante, P., Gaztambide, S., Bellido, D., Menéndez Torre, E., Ruiz-Valdepeñas, S., Bello, H., et al. (2023) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 36

Insulclock : A Novel Insulin Delivery Optimization and Tracking System

Gomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., & Ruiz, L. (2019) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 30

Efficacy of Insulclock in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial

Gomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., Cruz-Bravo, M., María-Sanchez, C., Poza, G., & Ruiz-Valdepeñas, L. (2020) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 25

A telehealth program using continuous glucose monitoring and a connected insulin pen cap in nursing homes for older adults with insulin-treated diabetes: the Trescasas study

Gomez-Peralta, F., Abreu, C., Santos, E., Da Silva, A., San Frutos, A., Vega-Valderrama, L., García-Galindo, M., Franco-López, A., López Mardomingo, C., Cañuelo, B., et al. (2025) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchTelemedicine and Telehealth Implementation

Cited by 11

Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis

Rudofsky, G., Menzen, M., Potier, L., Catarig, A.-M., Clark, A., Priyadarshini, P., & Abreu, C. (2025) · Advances in Therapy

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 3